$4.32
0.000100.00%
At close: -
$4.15
-0.17-3.94%
After Hours: Jan 17, 5:14 PM EDT
Xenetic Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Xenetic Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.28 | $-0.14 | -100.0 % |
Q2 | 2024-08-13 | $-0.83 | $-0.15 | -453.3 % |
Q1 | 2024-05-09 | $-0.78 | $-0.79 | 1.27 % |
Q4 | 2024-03-21 | $-0.77 | $-0.87 | 11.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $614.24K | $750.00K | -18.1 % |
Q2 | 2024-08-13 | $726.40K | $570.00K | 27.4 % |
Q1 | 2024-05-09 | $510.82K | $650.00K | -21.4 % |
Q4 | 2024-03-21 | $671.96K | $680.00K | -1.18 % |
Xenetic Biosciences (XBIO) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.28, which missed the estimate of $-0.14.
The Actual Revenue was $614.2K, which missed the estimate of $750K.
Browse earnings estimates, EPS, and revenue on all stocks.